Tenaya Therapeutics, Inc. (TNYA)
0.6687
-0.03
(-4.10%)
USD |
NASDAQ |
Aug 24, 16:00
0.6687
0.00 (0.00%)
After-Hours: 19:56
Tenaya Therapeutics Debt to Equity Ratio : 0.0569 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0569 |
| March 31, 2026 | 0.0953 |
| December 31, 2025 | 0.0879 |
| September 30, 2025 | 0.1391 |
| June 30, 2025 | 0.1223 |
| March 31, 2025 | 0.1081 |
| December 31, 2024 | 0.1466 |
| September 30, 2024 | 0.1291 |
| June 30, 2024 | 0.1162 |
| March 31, 2024 | 0.0719 |
| December 31, 2023 | 0.0891 |
| September 30, 2023 | 0.073 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.069 |
| March 31, 2023 | 0.0655 |
| December 31, 2022 | 0.062 |
| September 30, 2022 | 0.0818 |
| June 30, 2022 | 0.0759 |
| March 31, 2022 | 0.0609 |
| December 31, 2021 | 0.0564 |
| September 30, 2021 | 0.0534 |
| June 30, 2021 | -0.1523 |
| March 31, 2021 | -0.093 |
| December 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Intellia Therapeutics, Inc. | 0.1009 |
| Anavex Life Sciences Corp. | 0.00 |
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
| Oncolytics Biotech, Inc. | -0.0726 |
| Sangamo Therapeutics, Inc. | -1.020 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 93.54M |
| Total Liabilities (Quarterly) | 24.13M |
| Shareholders Equity (Quarterly) | 69.41M |
| Current Ratio | 4.522 |
| Net Debt Paydown Yield | 1.08% |